Details

NameSymbolSector
NECTAR LIFESCIENCES LIMITEDNECLIFEPharmaceuticals
Open
14.82
High
15.23
Low
14.46
Close
14.52
Volume
308314
Exchange
nse
Time
14/08

Outlook

Score:  

0

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Nectar Lifesciences is  
None
Estimated Stoploss of Nectar Lifesciences is ₹  
15.23
Nectar Lifesciences has a  
Bearishℹ
 pattern. 
Formation of  
None
 candle pattern indicates the trend direction of Nectar Lifesciences is  
Unpredictableℹ
. 

Trend

Nectar Lifesciences is in  
Strong Downtrendℹ
. 
Price of Nectar Lifesciences is  
Downℹ
 by  

20.48

%. 
Target
Buy @ 

13.05

Sell @ 

23.38

Volume

The trade volumes of Nectar Lifesciences have become  
Deficientℹ
The volume trend for Nectar Lifesciences is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Nectar Lifesciences is  

Down

 by  

89.25

% 

Valuation

The current market price of Nectar Lifesciences is  
Undervaluedℹ

Financials

Balance
The balance sheet of Nectar Lifesciences is:  

Balanced

Cashflow
Nectar Lifesciences has  
Poorℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

100

%. 

(*Mar 2025)

50% i.e. ₹ 169cr earned in operatingℹ
12.13% i.e. ₹ 41cr spent in investingℹ
37.87% i.e. ₹ 128cr spent in financingℹ
0% in otherℹ
Nectar Lifesciences has  
Sufficientℹ
 cash flow because there is  

Surplus

 of  

₹ 2cr

. It is  
Upℹ
 by  

0

%. 

(*Mar 2024)

50.22% i.e. ₹ 224cr earned in operatingℹ
3.81% i.e. ₹ 17cr spent in investingℹ
45.96% i.e. ₹ 205cr spent in financingℹ
0% in otherℹ
Income
The income of Nectar Lifesciences is  

₹ 281cr

 and  

Loss

 is :  

₹ 63cr

(*Jun 2025)

Nectar Lifesciences Losses decreased by:  

51.54

% and Income is Down by:  

34.65

% 

(*Jun 2025)

The income of Nectar Lifesciences is  

₹ 430cr

 and  

Loss

 is :  

₹ 130cr

(*Mar 2025)

Nectar Lifesciences Losses increased by:  

1957.14

% and Income is Down by:  

5.49

% 

(*Mar 2025)

The income of Nectar Lifesciences is  

₹ 455cr

 and  

Profit

 is :  

₹ 7cr

(*Dec 2024)

Nectar Lifesciences Profit is up by:  

40

% and Income is Up by:  

6.31

% 

(*Dec 2024)

By using this site you agree to the use of cookies to deliver a better site experience.